Griffith, Darren; Bergamo, Alberta; Pin, Sara; Vadori, Marta; Mueller-Bunz, Helge; Sava, Gianni; Marmion, Celine J. published the article 《Novel platinum pyridine-hydroxamic acid complexes: Synthesis, characterization, X-ray crystallographic study and nitric oxide related properties》. Keywords: pyridinehydroxamic acid preparation complexation platinum; crystal structure platinum pyridinehydroxamato chloro complex; platinum pyridinehydroxamato pyridinecarboxylato complex preparation; ruthenium nitrosyl chloro ethylenediaminetetraacetato complex preparation; vasorelaxation agent platinum pyridinehydroxamato pyridinecarboxylato complex; nitric oxide release platinum pyridinehydroxamato complex.They researched the compound: cis-Dichlorobis(pyridine)platinum(II)( cas:15227-42-6 ).Application In Synthesis of cis-Dichlorobis(pyridine)platinum(II). Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:15227-42-6) here.
We describe the synthesis and characterization of a novel class of PtII and PtIV pyridine-hydroxamic acid (pyhaH) complexes of general formula cis-[PtIICl2(x-pyhaH)2] and cis-[PtIVCl4(x-pyhaH)2], resp., (where x = 3 or 4) in which the pyridine-hydroxamic acid is coordinated to the platinum ion via the pyridine nitrogen only leaving the hydroxamic acid free to potentially release cytotoxic nitric oxide (NO). The crystal structure of the PtIV derivative, cis-[PtCl4(4-pyhaH)2]·2CH3OH is reported. To establish the biol. effect of the uncoordinated hydroxamic acid moiety in the PtII compounds, the corresponding pyridinecarboxylic acid (pycaH) complexes of general formula cis-[PtIICl2(x-pycaH)2] (where x = 3 or 4) and the PtII pyridine (py) complex cis-[PtIICl2(py)2] were synthesized and served as reference standards The NO-releasing properties of each of the PtII compounds, the pyhaH and the pycaH ligands were studied. The PtII pyridine-hydroxamic acid derivatives were found to induce potent in vitro effects attributable to either NO-release from the hydroxamic acid moiety and/or stimulation of inducible nitric oxide synthase of endothelial cells.
In some applications, this compound(15227-42-6)Application In Synthesis of cis-Dichlorobis(pyridine)platinum(II) is unique.If you want to know more details about this compound, you can contact with the author or consult more relevant literature.
Reference:
Tetrahydroisoquinoline – Wikipedia,
1,2,3,4-Tetrahydroisoquinoline | C9H11N – PubChem